AMAC1.md
... ...
@@ -13,9 +13,7 @@ nocite: |
13 13
14 14
## Relevance tier by entity
15 15
16
-|Entity|Tier|Description|
17
-|:------:|:----:|--------------------------------------|
18
-|![DLBCL](images/icons/DLBCL_tier3.png)|3|relevance in DLBCL not firmly established[@zhangGeneticHeterogeneityDiffuse2013]|
16
+[[include:table1_AMAC1.md]]
19 17
20 18
21 19
AMIGO3.md
... ...
@@ -13,9 +13,7 @@ nocite: |
13 13
14 14
## Relevance tier by entity
15 15
16
-|Entity|Tier|Description|
17
-|:------:|:----:|--------------------------------------|
18
-|![DLBCL](images/icons/DLBCL_tier3.png)|3|relevance in DLBCL not firmly established[@zhangGeneticHeterogeneityDiffuse2013]|
16
+[[include:table1_AMIGO3.md]]
19 17
20 18
21 19
AMN.md
... ...
@@ -13,9 +13,7 @@ nocite: |
13 13
14 14
## Relevance tier by entity
15 15
16
-|Entity|Tier|Description|
17
-|:------:|:----:|--------------------------------------|
18
-|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@spinaGeneticsNodalMarginal2016]|
16
+[[include:table1_AMN.md]]
19 17
20 18
21 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
AMOTL1.md
... ...
@@ -13,9 +13,7 @@ nocite: |
13 13
14 14
## Relevance tier by entity
15 15
16
-|Entity|Tier|Description|
17
-|:------:|:----:|--------------------------------------|
18
-|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@parryWholeExomeSequencing2013]|
16
+[[include:table1_AMOTL1.md]]
19 17
20 18
21 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
AMPH.md
... ...
@@ -13,9 +13,7 @@ nocite: |
13 13
14 14
## Relevance tier by entity
15 15
16
-|Entity|Tier|Description|
17
-|:------:|:----:|--------------------------------------|
18
-|![DLBCL](images/icons/DLBCL_tier3.png)|3|relevance in DLBCL not firmly established[@zhangGeneticHeterogeneityDiffuse2013]|
16
+[[include:table1_AMPH.md]]
19 17
20 18
21 19